Cargando…

Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report

Treatment of metastatic melanoma includes the option of targeted therapy in patients with driver BRAF mutations. BRAF-MEK inhibitor drugs improve survival in the approximately 50% of patients with melanoma that harbor BRAF mutations. As BRAF mutation detection in tissue often takes days to weeks, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behera, Tapas Ranjan, Song, Jung Min, Ko, Jennifer, Eicher, Donald, Arbesman, Joshua, Gastman, Brian, Farkas, Daniel H., Funchain, Pauline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231430/ https://www.ncbi.nlm.nih.gov/pubmed/35756682 http://dx.doi.org/10.3389/fonc.2022.846187

Ejemplares similares

Melanoma body site distribution: Germline genetics may have a lesser role
por: Decosma, Lorvens, et al.
Publicado: (2023)

Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016
por: Sussman, Tamara A, et al.
Publicado: (2022)

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
por: Sun, Lillian, et al.
Publicado: (2018)

Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities
por: Conti, Alfredo, et al.
Publicado: (2019)

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma
por: Shalata, Walid, et al.
Publicado: (2023)

Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma
por: Wu, Kan, et al.
Publicado: (2020)

The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer
por: Orlov-Slavu, Maria Cristina, et al.
Publicado: (2021)

Metastatic melanoma to the proximal ureter
por: DeSanto, Matthew, et al.
Publicado: (2023)

Circulating Melanoma Cells: Scoping the Target
por: Joshi, Powrnima, et al.
Publicado: (2013)

The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons
por: Sha, Jingfeng, et al.
Publicado: (2016)

High-Metastatic Melanoma Cells Promote the Metastatic Capability of Low-Metastatic Melanoma Cells via Exosomal Transfer of miR-411-5p
por: Chen, Hao, et al.
Publicado: (2022)

MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression
por: Chelakkot, Vipin Shankar, et al.
Publicado: (2023)

Association of Tumor Lysis Syndrome and Metastatic Melanoma
por: Kelkar, Neil, et al.
Publicado: (2021)

Commentary: High-metastatic melanoma cells promote the metastatic capability of low-metastatic melanoma cells via exosomal transfer of miR-411-5p
por: Li, Tianhang, et al.
Publicado: (2022)

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios
por: Khaddour, Karam, et al.
Publicado: (2022)

Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells
por: Venturelli, Sascha, et al.
Publicado: (2014)

Metastatic Melanoma to the Bladder: Case Report and Review of the Literature
por: Patil, Rohit V., et al.
Publicado: (2017)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
por: Khan, Shaheer, et al.
Publicado: (2022)

Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report
por: Schettini, Francesco, et al.
Publicado: (2022)

Lymphatic Transport Efficiency Determines Metastatic Potential of Cutaneous Melanoma
por: Holder, Ashley M., et al.
Publicado: (2020)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Bladder tumour as a first manifestation of metastatic choroid melanoma
por: Vieira e Brito, Duarte, et al.
Publicado: (2022)

Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1
por: Janka, Eszter Anna, et al.
Publicado: (2023)

Hypothesis: Is frequent, commercial jet travel by the general public a risk factor for developing cutaneous melanoma?
por: Arbesman, Harvey
Publicado: (2015)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
por: Zhao, Xiaobei, et al.
Publicado: (2019)

Robotic level II inferior vena cava thrombectomy for metastatic melanoma
por: Watson, Matthew J., et al.
Publicado: (2019)

Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study
por: Hadash-Bengad, Reut, et al.
Publicado: (2020)

Metastatic melanoma to the bladder presenting as autonomic dysreflexia in a patient with paraplegia
por: Abdou, Cherry A., et al.
Publicado: (2021)

New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma
por: Militaru, Ioana V., et al.
Publicado: (2023)

Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment
por: Zhang, Li, et al.
Publicado: (2023)

Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
por: Gianni, Caterina, et al.
Publicado: (2022)

Advances in Personalized Targeted Treatment of Metastatic Melanoma and Non-Invasive Tumor Monitoring
por: Klinac, Dragana, et al.
Publicado: (2013)

Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib
por: Sarkisian, Saro, et al.
Publicado: (2020)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
por: Wei, Alexander Z., et al.
Publicado: (2022)

Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
por: Stoff, Ronen, et al.
Publicado: (2022)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022)

A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells
por: Cameron, Cheryl M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2ri1vbumtssr3q2jij0vtndbk